Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
以治愈为目的治疗的结直肠癌患者的突变负荷和其他预后分子标志物:来自 QUASAR 2 临床试验和澳大利亚社区系列研究的结果
期刊:Lancet Gastroenterology & Hepatology
影响因子:38.6
doi:10.1016/S2468-1253(18)30117-1
Domingo, Enric; Camps, Carme; Kaisaki, Pamela J; Parsons, Marie J; Mouradov, Dmitri; Pentony, Melissa M; Makino, Seiko; Palmieri, Michelle; Ward, Robyn L; Hawkins, Nicholas J; Gibbs, Peter; Askautrud, Hanne; Oukrif, Dahmane; Wang, Haitao; Wood, Joe; Tomlinson, Evie; Bark, Yasmine; Kaur, Kulvinder; Johnstone, Elaine C; Palles, Claire; Church, David N; Novelli, Marco; Danielsen, Havard E; Sherlock, Jon; Kerr, David; Kerr, Rachel; Sieber, Oliver; Taylor, Jenny C; Tomlinson, Ian